News | Radiation Oncology | July 13, 2015

Company's RegistrationQX platform provides automated, quantitative assessment of DIR to eliminate inter-user variability

Mirada Medical, deformable image registration, DIR, QA, RegistrationQX, AAPM

July 13, 2015 - Mirada Medical and collaborators from the University Medical Center, Groningen, The Netherlands, will present new research on quality assurance of deformable image registration (DIR) at the annual meeting of the American Association of Medical Physicists (AAPM). Accurate definition of targets and critical structures is essential for the planning and delivery of radiation therapy and radiosurgery. DIR is increasingly utilized during treatment planning to aid in this process.

A critical step in deploying DIR in the clinic is quality assurance of the result. To date, this has been typically performed qualitatively using tools such as fusion overlays and inspection of the deformation field, requiring a user experienced with DIR, patient anatomy and the clinical context. Such an approach is subjective and can lead to significant inter-user variability. Existing quantitative tools such as measuring target registration error and dice overlap of structures are practical for commissioning and research but are often too labor-intensive for clinical use.

Mirada Medical and collaborators will be introducing RegistrationQX, a novel technique to overcome these limitations. RegistrationQX uses a set of quantitative measurements of the deformation quality, numerical robustness and matching to assist the user in assessing the quality of a DIR result. With the release of RegistrationQX, clinical staff will be able to augment their visual DIR quality assurance with an automatically generated quantitative report. The original research compares the quantitative scores produced by RegistrationQX with grading scores produced by experts with significant experience in using DIR clinically on 27 head and neck patients. Good correlation (0.86) was observed between the automatic and manual scores indicating that the quantitative scores reflected the opinions of the experts.

RegistrationQX and this study form part of Mirada's Registration Assurance program, a comprehensive program for ensuring DIR quality and continuous improvement through rigorous scientific validation of technology, education, comprehensive QC tools and a commitment to ongoing development and support. The registration workflows used in the study are all available in the new releases of Mirada RTx and Mirada Workflow Box.

For more information: www.mirada-medical.com


Related Content

News | Innovative Hospitals

July 27, 2026 — Vanderbilt Health and Siemens Healthineers have entered into a multi-year, $87 million Value ...

Time July 28, 2026
arrow
News | ASTRO

July 22, 2026 — The American Society for Radiation Oncology (ASTRO) has announced the 39 members who will receive the ...

Time July 23, 2026
arrow
News | PET Imaging

July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...

Time July 15, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

June 9, 2026 — An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for ...

Time June 15, 2026
arrow
News | Radiation Therapy

June 3, 2026 — Alpha Tau Medical Ltd. and Tolmar International Ltd. have announced a strategic collaboration agreement ...

Time June 04, 2026
arrow
News | Ultrasound Imaging

May 26, 2026 — A soft, wearable ultrasound patch that can continuously monitor a fetus for hours at a time — and it can ...

Time May 27, 2026
arrow
News | ASTRO

May 18, 2026 — The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and ...

Time May 19, 2026
arrow
News | Radiation Therapy

April 30, 2026 — The Siemens Healthineers business area, Varian, has been awarded up to $60 million over five years by ...

Time April 30, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
Subscribe Now